With the analysis among 848 patents, we discovered top 155 key players by total patent application. Pfizer Inc., Juno Therapeutics, Inc., Eureka Therapeutics, Inc. are dominant in this area. They take 21.34% of the total patent filing.
New York, United States
Patent: 57
Washington, United States
Patent: 53
Eureka Therapeutics, Inc.
California, United States
Patent: 52
New Jersey, United States
Patent: 47
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 44
Harpoon Therapeutics, Inc.
California, United States
Patent: 40
Allogene Therapeutics, Inc.
California, United States
Patent: 34
Louisiana, United States
Patent: 33
Northwest Biotherapeutics, Inc.
With the analysis among 56 patents, we discovered top 13 start-ups by total patent application. DRAGONFLY Therapeutics, Inc., LISCure Bioscience Co. Ltd., Institut National de la Santé et de la Recherche Médicale are active in this area.
DRAGONFLY Therapeutics, Inc.
Massachusetts, United States
Patent: 15
LISCure Bioscience Co. Ltd.
Institut National de la Santé et de la Recherche Médicale
Huadao (Shanghai) Biomedical Co., Ltd.
Shanghai Shi, China
Patent: 5
Adicet Therapeutics, Inc.
California, United States
Patent: 2
Hrain Biotechnology Co. Ltd.
Shanghai Shi, China
Patent: 2
Cartesian Therapeutics, Inc.
California, United States
Patent: 2
Nanjing IASO Biotherapeutics Co., Ltd.
Jiangsu Sheng, China
Patent: 1
With the analysis among related 672 patents applied in the last 5 years. We discover 153 most active companies in this area. The fast-growing Juno Therapeutics, Inc., Celgene Corp., Regeneron Pharmaceuticals, Inc. take 21.43% of patent filing during this period.
Washington, United States
Patent: 53
New Jersey, United States
Patent: 47
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 44
Harpoon Therapeutics, Inc.
California, United States
Patent: 40
Dana-Farber Cancer Institute, Inc.
Massachusetts, United States
Patent: 37
Allogene Therapeutics, Inc.
California, United States
Patent: 34
Louisiana, United States
Patent: 33
Memorial Sloan-Kettering Cancer Center
New York, United States
Patent: 31
Springworks Therapeutics, Inc.
Connecticut, United States
Patent: 21
With the analysis among related 672 patents in last 5 years, we discover 125 new entrants. Juno Therapeutics, Inc., Celgene Corp., Regeneron Pharmaceuticals, Inc. are the most active new entrants in this area.
Washington, United States
Patent: 53
New Jersey, United States
Patent: 47
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 44
Harpoon Therapeutics, Inc.
California, United States
Patent: 40
Dana-Farber Cancer Institute, Inc.
Massachusetts, United States
Patent: 37
Allogene Therapeutics, Inc.
California, United States
Patent: 34
Louisiana, United States
Patent: 33
Springworks Therapeutics, Inc.
Connecticut, United States
Patent: 21
DRAGONFLY Therapeutics, Inc.
Massachusetts, United States
Patent: 15
Shanghai EpimAb Biotherapeutics Co. Ltd.
Shanghai Shi, China
Patent: 12
With the analysis among 234 patents, we discovered top 35 universities and scientific research institutions by total patent application. President & Fellows of Harvard College, University of Bristol, University of Barcelona are dominant in this area. They take 70.94% of the total patent filing.
President & Fellows of Harvard College
Massachusetts, United States
Patent: 43
BRISTOL, United Kingdom
Patent: 8
Beijing Shi, China
Patent: 5
The Salk Institute for Biological Studies
California, United States
Patent: 4
New York, United States
Patent: 3
Washington, United States
Patent: 2
The Johns Hopkins University
Shanghai Shi, China
Patent: 2